Order Article Reprints

Troike KM, Acanda de la Rocha AM, Alban TJ, Grabowski MM, Otvos B, Cioffi G, Waite KA, Barnholtz Sloan JS, Lathia JD, Guilarte TR, et al. The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients. Cancers. 2021; 13(18):4525. https://doi.org/10.3390/cancers13184525

Troike, Katie M., Arlet M. Acanda de la Rocha, Tyler J. Alban, Matthew M. Grabowski, Balint Otvos, Gino Cioffi, Kristin A. Waite, Jill S. Barnholtz Sloan, Justin D. Lathia, Tomás R. Guilarte, and et al. 2021. "The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients" Cancers 13, no. 18: 4525. https://doi.org/10.3390/cancers13184525

Troike, K. M., Acanda de la Rocha, A. M., Alban, T. J., Grabowski, M. M., Otvos, B., Cioffi, G., Waite, K. A., Barnholtz Sloan, J. S., Lathia, J. D., Guilarte, T. R., & Azzam, D. J. (2021). The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients. Cancers, 13(18), 4525. https://doi.org/10.3390/cancers13184525